SMI Expanded
1.735,72
PKT
+9,91
PKT
+0,57
%
Werbung
Analysen zu SMI Expanded-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 06.05.19 | Zurich Insurance Equal weight | Barclays Capital | |
| 06.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 03.05.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 03.05.19 | Swiss Re overweight | JP Morgan Chase & Co. | |
| 03.05.19 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 03.05.19 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 03.05.19 | Swiss Re Sector Perform | RBC Capital Markets | |
| 03.05.19 | Swiss Re Sell | UBS AG | |
| 03.05.19 | ams-OSRAM buy | Hauck & Aufhäuser Privatbankiers KGaA | |
| 02.05.19 | Holcim overweight | Morgan Stanley | |
| 02.05.19 | Holcim Sell | UBS AG | |
| 02.05.19 | ams-OSRAM buy | Kepler Cheuvreux | |
| 02.05.19 | ams-OSRAM buy | Oddo BHF | |
| 02.05.19 | ams-OSRAM Neutral | UBS AG | |
| 02.05.19 | UBS Equal weight | Barclays Capital | |
| 02.05.19 | ams-OSRAM overweight | Barclays Capital | |
| 01.05.19 | ams-OSRAM buy | Deutsche Bank AG | |
| 30.04.19 | Roche overweight | Morgan Stanley | |
| 30.04.19 | ams-OSRAM Neutral | UBS AG | |
| 30.04.19 | ams-OSRAM Underperform | Credit Suisse Group | |
| 30.04.19 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 30.04.19 | ams-OSRAM overweight | Barclays Capital | |
| 30.04.19 | ams-OSRAM Neutral | JP Morgan Chase & Co. | |
| 29.04.19 | UBS Sector Perform | RBC Capital Markets | |
| 29.04.19 | UBS Sector Perform | RBC Capital Markets | |
| 29.04.19 | Nestlé buy | Goldman Sachs Group Inc. | |
| 26.04.19 | UBS Hold | Kepler Cheuvreux | |
| 26.04.19 | UBS Outperform | Credit Suisse Group | |
| 26.04.19 | UBS buy | HSBC | |
| 25.04.19 | Novartis Neutral | Credit Suisse Group | |
| 25.04.19 | Novartis Hold | Deutsche Bank AG | |
| 25.04.19 | Novartis Hold | HSBC | |
| 25.04.19 | Novartis buy | Jefferies & Company Inc. | |
| 25.04.19 | UBS buy | UBS AG | |
| 25.04.19 | UBS Neutral | Goldman Sachs Group Inc. | |
| 25.04.19 | UBS Sector Perform | RBC Capital Markets | |
| 25.04.19 | UBS overweight | JP Morgan Chase & Co. | |
| 25.04.19 | UBS Hold | Deutsche Bank AG | |
| 25.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. |